Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yi-Yu Chen
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Kaohsiung Medical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Kaohsiung Municipal Hsiao-Kang Hospital
ORCID:
0009-0006-5933-0612
Observed ORCID:
0009-0006-5933-0612
OpenAlex ID:
A5107484337
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
2025
·
Tong Fu
, Xi Jin
, et al.
·
Science Translational Medicine
·
31
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
·
Cancer Research
·
11
Decrease in Ankle-Brachial Index Over Time and Cardiovascular Outcomes in Patients With Hemodialysis
2012
·
Szu-Chia Chen
, Wan-Chun Liu
, et al.
·
The American Journal of the Medical Sciences
·
9
Table S6 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S2 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S1 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S8 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S8 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S3 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S4 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Data from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S1 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S2 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S6 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S7 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S5 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S4 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Figure S7 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S3 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Table S5 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2025
·
Xiu-Zhi Zhu
, Hu-Yun-Long Zhang
, et al.
Show more works
View as search
Works count:
20
Citation count:
51
H-index:
3
I10-index:
2
Year
Topic
Type